August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...
August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body ...
August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of ...
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...
August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 29, 2022 — The US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to ...
August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...
August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program ...
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel ...